缺血性卒中血流再通时代的脑细胞保护新策略
Brain cytoprotection of ischemic stroke in the era of effective reperfusion作者机构:Department of Neurology and China-America Institute of NeuroscienceXuanwu HospitalCapital Medical UniversityBeijing 100053China Bejing Institute of Brain DisordersCapital Medical UniversityBeijing 100053China Departmentof NeurologyBeth Israel Deaconess Medical CenterHarvard Medical SchoolBoston 02215USA
出 版 物:《Science Bulletin》 (科学通报(英文版))
年 卷 期:2022年第67卷第23期
页 面:2372-2375页
核心收录:
学科分类:1002[医学-临床医学] 100204[医学-神经病学] 10[医学]
基 金:supported by the National Natural Science Foundation of China (82027802 82071466 and 82102220)
摘 要:Acute ischemic stroke (AIS) treatment has been advanced by the development of recanalization therapies, especially endovascular thrombectomy. Thrombectomy has led to a better prognosis at 90 d not only in stroke patients because of large-vessel occlusion in the proximal anterior cerebral circulation, but also in those due to basilar-artery occlusion [1]. Thus, the number of eligible patients for revascularization will continue to increase.